Top
Main
 
All Outcomes
 
Feedback
Home
c19early.org COVID-19 treatment researchLeritrelvirLeritrelvir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

Loading...
More

Supplementary Data — Leritrelvir for COVID-19: real-time meta analysis of 2 studies

@CovidAnalysis, July 2024, Version 1V1
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Wang (DB RCT) 35% 0.65 [0.43-0.97] recov. time 20 (n) 20 (n) Improvement, RR [CI] Treatment Control Wang (DB RCT) 21% 0.79 [0.67-0.95] viral load 20 (n) 20 (n) Wang (DB RCT) 11% 0.89 [0.74-1.07] viral load 20 (n) 20 (n) Wang (DB RCT) 52% 0.48 [0.22-1.00] viral+ 20 (n) 20 (n) Wang (DB RCT) 80% 0.20 [0.09-0.45] viral+ 20 (n) 20 (n) Zhan (DB RCT) 17% 0.83 [0.74-0.93] no recov. 680 (n) 679 (n) Zhan (DB RCT) 14% 0.86 [0.77-0.97] no recov. 680 (n) 679 (n) Zhan (DB RCT) 21% 0.79 [0.63-0.98] no recov. 111/680 141/679 Zhan (DB RCT) 22% 0.78 [0.60-1.01] no recov. 89/680 114/679 Zhan (DB RCT) 16% 0.84 [0.73-0.96] viral+ 231/680 275/679 Leritrelvir COVID-19 outcomes c19early.org July 2024 Favors leritrelvir Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit